Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 7
2004 5
2005 3
2006 7
2007 6
2008 7
2009 7
2010 5
2011 6
2012 9
2013 4
2014 13
2015 11
2016 11
2017 12
2018 10
2019 14
2020 32
2021 26
2022 24
2023 18
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

226 results

Results by year

Filters applied: . Clear all
Page 1
Keeping university open did not increase the risk of SARS-CoV-2 acquisition: A test negative case-control study among students.
Renzi E, Baccolini V, Covelli A, Siena LM, Sciurti A, Migliara G, Massimi A, Marzuillo C, De Vito C, Casini L, Angeloni A, Turriziani O, Antonelli G, D'Alba F, Polimeni A; Collaborating Group; Villari P. Renzi E, et al. Among authors: antonelli g. PLoS One. 2024 Mar 27;19(3):e0301215. doi: 10.1371/journal.pone.0301215. eCollection 2024. PLoS One. 2024. PMID: 38536834 Free PMC article.
Age-related transcript changes in type I interferon signaling in children and adolescents with long COVID.
Fracella M, Mancino E, Nenna R, Virgillito C, Frasca F, D'Auria A, Sorrentino L, Petrarca L, La Regina D, Matera L, Di Mattia G, Caputo B, Antonelli G, Pierangeli A, Viscidi RP, Midulla F, Scagnolari C. Fracella M, et al. Among authors: antonelli g. Eur J Immunol. 2024 Mar 24:e2350682. doi: 10.1002/eji.202350682. Online ahead of print. Eur J Immunol. 2024. PMID: 38522030
Molecular monitoring of viral infections in immunocompromised patients in a large university hospital in Italy: reflections after thirteen years of real-life activity.
Cinti L, Roberto P, Rossi M, Napoli A, Russo G, Iori AP, Gentile G, Augurusa M, Girmenia C, Antonelli G, Gaeta A. Cinti L, et al. Among authors: antonelli g. Eur J Clin Microbiol Infect Dis. 2024 Mar 22. doi: 10.1007/s10096-024-04812-z. Online ahead of print. Eur J Clin Microbiol Infect Dis. 2024. PMID: 38517571
COVID-19 vaccination in cancer patients: Immune responses one year after the third dose.
Campagna R, Dominelli F, Zingaropoli MA, Ciurluini F, Grilli G, Amoroso A, De Domenico A, Amatore D, Lia MS, Cortesi E, Picone V, Mastroianni CM, Ciardi MR, De Santis R, Lista F, Antonelli G, Turriziani O. Campagna R, et al. Among authors: antonelli g. Vaccine. 2024 Apr 11;42(10):2687-2694. doi: 10.1016/j.vaccine.2024.03.017. Epub 2024 Mar 17. Vaccine. 2024. PMID: 38499458 Free article.
The Epidemiology of Anal Human Papillomavirus (HPV) in HIV-Positive and HIV-Negative Women and Men: A Ten-Year Retrospective Observational Study in Rome (Italy).
Fracella M, Oliveto G, Roberto P, Cinti L, Gentile M, Coratti E, D'Ettorre G, Cavallari EN, Romano F, Santinelli L, Maddaloni L, Frasca F, Scagnolari C, Antonelli G, Pierangeli A. Fracella M, et al. Among authors: antonelli g. Pathogens. 2024 Feb 11;13(2):163. doi: 10.3390/pathogens13020163. Pathogens. 2024. PMID: 38392901 Free PMC article.
Presence of neutralizing SARS-CoV-2 antibodies in asymptomatic population of N'Djamena, Chad.
Wondeu ALD, Abakar MF, Frasca F, Nodjikouambaye AZ, Abdelrazakh F, Naibei N, Dzomo GRT, Djimtoibaye D, Mad-Toingue J, Scagnolari C, Antonelli G, Linardos G, Russo C, Perno CF, Yandai FH, Atturo S, Hiscott J, Colizzi V, Cappelli G, Ngueadoum N, Haroun A, Choua O, Moussa AM. Wondeu ALD, et al. Among authors: antonelli g. Immun Inflamm Dis. 2024 Jan;12(1):e1154. doi: 10.1002/iid3.1154. Immun Inflamm Dis. 2024. PMID: 38270301 Free PMC article.
Corrigendum to "Virological and clinical rebounds of COVID-19 soon after nirmatrelvir/ritonavir discontinuation" [Clin Microbiol Infect 28 (12) (2022 Dec) 1657-1658].
Antonelli G, Focosi D, Turriziani O, Tuccori M, Brandi R, Fillo S, Ajassa C, Lista F, Mastroianni CM. Antonelli G, et al. Clin Microbiol Infect. 2024 Mar;30(3):408. doi: 10.1016/j.cmi.2023.12.014. Epub 2023 Dec 14. Clin Microbiol Infect. 2024. PMID: 38103639 Free PMC article. No abstract available.
SARS-CoV-2 pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) provides protection in inborn errors of immunity with antibody defects: a real-world experience.
Pulvirenti F, Garzi G, Milito C, Sculco E, Sciannamea M, Napoli A, Cinti L, Roberto P, Punziano A, Carrabba M, Piano Mortari E, Carsetti R, Antonelli G, Quinti I. Pulvirenti F, et al. Among authors: antonelli g. Front Immunol. 2023 Oct 26;14:1249462. doi: 10.3389/fimmu.2023.1249462. eCollection 2023. Front Immunol. 2023. PMID: 37954618 Free PMC article.
Differential expression of Type I interferon and inflammatory genes in SARS-CoV-2-infected patients treated with monoclonal antibodies.
Maddaloni L, Santinelli L, Bugani G, Cacciola EG, Lazzaro A, Lofaro CM, Caiazzo S, Frasca F, Fracella M, Ajassa C, Leanza C, Napoli A, Cinti L, Gaeta A, Antonelli G, Ceccarelli G, Mastroianni CM, Scagnolari C, d'Ettorre G. Maddaloni L, et al. Among authors: antonelli g. Immun Inflamm Dis. 2023 Oct;11(10):e968. doi: 10.1002/iid3.968. Immun Inflamm Dis. 2023. PMID: 37904704 Free PMC article.
Interferon-ε as potential inhibitor of Chlamydia trachomatis infection.
Filardo S, Di Pietro M, Bozzuto G, Fracella M, Bitossi C, Molinari A, Scagnolari C, Antonelli G, Sessa R. Filardo S, et al. Among authors: antonelli g. Microb Pathog. 2023 Dec;185:106427. doi: 10.1016/j.micpath.2023.106427. Epub 2023 Oct 27. Microb Pathog. 2023. PMID: 37890679 Free article.
226 results